O2matic’s Autonomous Oxygen Therapy Technology to Be Evaluated in U.S. Prehospital Study Funded by Department of Defense

Copenhagen, Denmark – December 1st, 2025 – O2matic ApS, a digital health company pioneering autonomous oxygen therapy and monitoring technologies, announced today that its proprietary oxygen titration system will be…

Continue ReadingO2matic’s Autonomous Oxygen Therapy Technology to Be Evaluated in U.S. Prehospital Study Funded by Department of Defense

Improving patients’ life with home oxygen therapy and taking PRO100 to next level

Slagelse Hospital has been using PRO100 since 2020 and has in 2024 decided to integrate the treatment deeper into pulmonary ward. 18 PRO100 devices are ready to manage oxygen therapy…

Continue ReadingImproving patients’ life with home oxygen therapy and taking PRO100 to next level

O2matic’s Proprietary Technology to be Evaluated by the University of Colorado, Funded by the U.S. Department of Defense

O2matic’s Proprietary Technology to be Evaluated by the University of Colorado, Funded by the U.S. Department of Defense Copenhagen May 21, 2024 - O2matic, a Danish medical device company focused…

Continue ReadingO2matic’s Proprietary Technology to be Evaluated by the University of Colorado, Funded by the U.S. Department of Defense